Imodium (Loperamide Hydrochloride)

Loperamide Hydrochloride binds to peripheral μ‑opioid receptors in the gut wall. This binding decreases smooth‑muscle activity, slows the transit of intestinal contents, and promotes absorption of water and electrolytes. The result is firmer stools and fewer bowel movements without significant central nervous system effects.

The appropriate dose of Imodium is determined by a prescriber based on the patient’s age, weight, severity of diarrhea, and clinical response. Healthcare professionals tailor the regimen to each individual, and patients should follow the specific instructions provided by their doctor or pharmacist.

Safety of Imodium during pregnancy or lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this medication.

To order Imodium, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The team then replies with pricing, availability, shipping details and any necessary import documentation.

Imodium (loperamide) is a peripheral μ‑opioid receptor agonist, whereas other antidiarrheals such as bismuth subsalicylate act by coating the gut lining and reducing inflammation. Loperamide provides rapid reduction of stool frequency without systemic opioid effects, making it a preferred choice for many acute and chronic diarrheal conditions.

Imodium should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Imodium is taken orally, usually as a tablet or capsule, with or without water. The exact method of administration, including whether to take it with food, is determined by the prescribing clinician and should be followed as directed on the prescription label.

Serious risks include severe constipation, ileus, toxic megacolon, cardiac arrhythmias (especially QT prolongation), and allergic reactions such as rash or anaphylaxis. Patients should seek immediate medical attention if they experience abdominal pain, vomiting, or any signs of a severe reaction.

Imodium should be avoided in individuals with known hypersensitivity to loperamide, those with active bacterial enterocolitis, pseudomembranous colitis, or unexplained fever and abdominal pain. It is also contraindicated in patients with severe liver disease or in whom intestinal motility should not be reduced.